Sabine Madaus
Plus aucun poste en cours
Profil
Ms. Sabine Madaus is an Investment Manager at GoodVent Beteiligungsmanagement GmbH & Co. KG.
She is on the Board of Directors at IMTM GmbH and 3 C Membrane AG.
Ms. Madaus was previously employed as Managing Partner by IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH.
She also served on the board at KeyNeurotek Pharmaceuticals AG.
Anciens postes connus de Sabine Madaus
| Sociétés | Poste | Fin |
|---|---|---|
3 C Membrane AG
 3 C Membrane AG Industrial MachineryProducer Manufacturing 3C Membrane AG is an industrial company, active in the production and worldwide sales of innovative ceramic filter elements, set to lead in price and performance in this segment. Its plant in Halberstadt, Germany, was built in 2003 and commands one of the largest capacities worlds wide for the production of ceramic membranes. The company was founded in 2008 and is headquartered in Halberstadt, Germany. | Directeur/Membre du Conseil | 27/11/2013 |
GoodVent Beteiligungsmanagement GmbH & Co. KG
 GoodVent Beteiligungsmanagement GmbH & Co. KG Investment ManagersFinance GoodVent Beteiligungsmanagement GmbH & Co. KG is a private equity firm located in Magdeburg in the central-eastern part of Germany. The firm originated in 2000 to take over the business of the pre-existing investment arm of Land Sachsen-Anhalt. Previously known as IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the firm was privatized in 2007, and was briefly renamed Acceres Beteiligungsmanagement GmbH & Co. KG. GoodVent manages the IBG venture capital funds. | Private Equity Investor | 01/01/2012 |
KeyNeurotek Pharmaceuticals AG
 KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany. | Directeur/Membre du Conseil | 03/08/2011 |
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
 IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH Investment ManagersFinance Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg. | Corporate Officer/Principal | 01/08/2007 |
IMTM GmbH
 IMTM GmbH Medical SpecialtiesHealth Technology IMTM GmbH is engaged in the development of therapeutic drugs for the treatment of immune dysfunction diseases and conditions. The firm specializes in silico, in vitro, and in vivo methods that focus on the discovery, optimization, and analysis of drug candidates. Its service areas encompass drug design, pharmaceutical development, experimental medicine research, clinical trials, and laboratory testing. The company was founded in 1996 and is headquartered in Magdeburg, Germany. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH Investment ManagersFinance Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg. | Finance |
KeyNeurotek Pharmaceuticals AG
KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany. | Health Technology |
GoodVent Beteiligungsmanagement GmbH & Co. KG
GoodVent Beteiligungsmanagement GmbH & Co. KG Investment ManagersFinance GoodVent Beteiligungsmanagement GmbH & Co. KG is a private equity firm located in Magdeburg in the central-eastern part of Germany. The firm originated in 2000 to take over the business of the pre-existing investment arm of Land Sachsen-Anhalt. Previously known as IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the firm was privatized in 2007, and was briefly renamed Acceres Beteiligungsmanagement GmbH & Co. KG. GoodVent manages the IBG venture capital funds. | Finance |
IMTM GmbH
IMTM GmbH Medical SpecialtiesHealth Technology IMTM GmbH is engaged in the development of therapeutic drugs for the treatment of immune dysfunction diseases and conditions. The firm specializes in silico, in vitro, and in vivo methods that focus on the discovery, optimization, and analysis of drug candidates. Its service areas encompass drug design, pharmaceutical development, experimental medicine research, clinical trials, and laboratory testing. The company was founded in 1996 and is headquartered in Magdeburg, Germany. | Health Technology |
3 C Membrane AG
3 C Membrane AG Industrial MachineryProducer Manufacturing 3C Membrane AG is an industrial company, active in the production and worldwide sales of innovative ceramic filter elements, set to lead in price and performance in this segment. Its plant in Halberstadt, Germany, was built in 2003 and commands one of the largest capacities worlds wide for the production of ceramic membranes. The company was founded in 2008 and is headquartered in Halberstadt, Germany. | Producer Manufacturing |
